| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| M Gassen, I Lamensdorf, T Armony, J P M Finberg, M B H Youdi. Attenuation of methamphetamine induced dopaminergic neurotoxicity by flupirtine: microdialysis study on dopamine release and free radical generation. Journal of neural transmission (Vienna, Austria : 1996). vol 110. issue 2. 2003-07-11. PMID:12589576. |
work in models of monoamine depletion and neuroleptic induced catalepsy in rats suggests a interaction of flupirtine with the dopaminergic neurotransmitter system as well. |
2003-07-11 |
2023-08-12 |
mouse |
| Päivi Tuomainen, Anton Patsenka, Petri Hyytiä, Vladimir Grinevich, Kalervo Kiianma. Extracellular levels of dopamine in the nucleus accumbens in AA and ANA rats after reverse microdialysis of ethanol into the nucleus accumbens or ventral tegmental area. Alcohol (Fayetteville, N.Y.). vol 29. issue 2. 2003-07-11. PMID:12782253. |
the findings support the suggestion that the increase in the extracellular level of dopamine in the nucleus accumbens after systemic administration of ethanol may involve other sites on dopamine neurons or even different neurotransmitter systems, rather than the action of ethanol at the mesolimbic dopaminergic terminals. |
2003-07-11 |
2023-08-12 |
rat |
| Mario F Wullimann, Thomas Muelle. Expression of Zash-1a in the postembryonic zebrafish brain allows comparison to mouse Mash1 domains. Brain research. Gene expression patterns. vol 1. issue 3-4. 2003-07-03. PMID:12638130. |
subpallial gabaergic interneurons versus pallial glutamatergic projection neurons, or dopaminergic neurons versus other neurotransmitter phenotypes). |
2003-07-03 |
2023-08-12 |
mouse |
| J Kirschner, G H Moll, U M Fietzek, H Heinrich, V Mall, S Berweck, F Heinen, A Rothenberge. Methylphenidate enhances both intracortical inhibition and facilitation in healthy adults. Pharmacopsychiatry. vol 36. issue 2. 2003-07-01. PMID:12734766. |
enhancement of both of these tms parameters was unexpected and suggests that mph exerts its action on the motor cortex not only through the dopaminergic neurotransmitter system. |
2003-07-01 |
2023-08-12 |
Not clear |
| Jeffery D Stekete. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain research. Brain research reviews. vol 41. issue 2-3. 2003-06-10. PMID:12663081. |
these pyramidal neurons are modulated by numerous neurotransmitter systems, including gamma-aminobutyric acidergic interneurons and dopaminergic, noradrenergic, serotonergic, glutamatergic, cholinergic and peptidergic afferents. |
2003-06-10 |
2023-08-12 |
Not clear |
| J-C Seznec, J-P Lépine, A Pélissol. [Dimensional personality assessment of the members of the French junior national team of road cycling]. L'Encephale. vol 29. issue 1. 2003-05-14. PMID:12640324. |
these personality traits are hypothetically related to underlying neurotransmitter systems (especially ns to dopaminergic function and ha to serotonergic function). |
2003-05-14 |
2023-08-12 |
human |
| Andreas Reif, Klaus-Peter Lesc. Toward a molecular architecture of personality. Behavioural brain research. vol 139. issue 1-2. 2003-05-02. PMID:12642172. |
in recent years, molecular genetics has begun to identify specific genes coding in particular for components of the serotonergic and dopaminergic neurotransmitter systems representing quantitative trait loci (qtls) for behavioral traits. |
2003-05-02 |
2023-08-12 |
Not clear |
| J Ludovic Croxfor. Therapeutic potential of cannabinoids in CNS disease. CNS drugs. vol 17. issue 3. 2003-03-31. PMID:12617697. |
evidence suggests that cannabinoids may prove useful in parkinson's disease by inhibiting the excitotoxic neurotransmitter glutamate and counteracting oxidative damage to dopaminergic neurons. |
2003-03-31 |
2023-08-12 |
Not clear |
| Channi Kumar, Ronan J McIvor, Tony Davies, Nigel Brown, Andrew Papadopoulos, Angelika Wieck, Stuart A Checkley, Iain C Campbell, Maureen N Mark. Estrogen administration does not reduce the rate of recurrence of affective psychosis after childbirth. The Journal of clinical psychiatry. vol 64. issue 2. 2003-03-26. PMID:12633118. |
these relapses may be triggered by the postdelivery fall in circulating estrogen through alteration of central neurotransmitter (especially dopaminergic) systems. |
2003-03-26 |
2023-08-12 |
Not clear |
| Brian M Ross, Robert J Brooks, Margaret Lee, Kathryn S Kalasinsky, Shawn P Vorce, Mary Seeman, Paul J Fletcher, Sylvie D Turenn. Cyclooxygenase inhibitor modulation of dopamine-related behaviours. European journal of pharmacology. vol 450. issue 2. 2003-03-24. PMID:12206852. |
their apparent ability to antagonise hypoactivity without generalised dopaminergic stimulation suggests that other, possibly multiple, neurotransmitter systems may be involved. |
2003-03-24 |
2023-08-12 |
rat |
| Manolis Markianos, John Hatzimanolis, Lefteris Lykoura. Relationship between prolactin responses to ECT and dopaminergic and serotonergic responsivity in depressed patients. European archives of psychiatry and clinical neuroscience. vol 252. issue 4. 2003-02-24. PMID:12242577. |
the prolactin (prl) increases in plasma, induced by the electrical stimulus during electroconvulsive therapy (ect), is a consistent finding that can be studied in order to obtain information about its actions on the brain neurotransmitter systems, the most probable candidates being the serotonergic and the dopaminergic system. |
2003-02-24 |
2023-08-12 |
human |
| Pippa S Loupe, Jonna D Bredemeier, Stephen R Schroeder, Richard E Tesse. Dopamine re-uptake inhibitor GBR-12909 induction of aberrant behaviors in animal models of dopamine dysfunction. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience. vol 20. issue 3-5. 2002-12-17. PMID:12175869. |
brain imaging studies have found that several of these individuals have abnormalities in their dopaminergic neurotransmitter systems that are thought to be responsible in part, for the development of these behaviors. |
2002-12-17 |
2023-08-12 |
rat |
| Jean-Denis Troadec, Marc Marien, Sophie Mourlevat, Thomas Debeir, Merle Ruberg, Francis Colpaert, Patrick P Miche. Activation of the mitogen-activated protein kinase (ERK(1/2)) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons. Molecular pharmacology. vol 62. issue 5. 2002-11-12. PMID:12391266. |
activation of the mitogen-activated protein kinase (erk(1/2)) signaling pathway by cyclic amp potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons. |
2002-11-12 |
2023-08-12 |
Not clear |
| T Mülle. Non-dopaminergic drug treatment of Parkinson's disease. Expert opinion on pharmacotherapy. vol 2. issue 4. 2002-11-06. PMID:11336607. |
several lines of evidence suggest that substitution of the dopaminergic striatal deficit only represents one important aspect of the treatment of parkinson's disease (pd) because neurotransmitter systems other than the dopaminergic one also degenerate and aggravate parkinsonian motor, vegetative and cognitive symptoms. |
2002-11-06 |
2023-08-12 |
Not clear |
| Henry F Bradfor. The use of foetal human brain tissue as brain implants: phenotype manipulation by genetic manipulation and biochemical induction. The Keio journal of medicine. vol 51. issue 3. 2002-10-29. PMID:12371646. |
in another approach we have biochemically manipulated the development of the cerebral cortex to direct the neurotransmitter phenotype towards the dopaminergic type, and away from other phenotypes. |
2002-10-29 |
2023-08-12 |
human |
| Adam Czapliński, Andreas J Steck, Peter Fuh. [Tic syndrome]. Neurologia i neurochirurgia polska. vol 36. issue 3. 2002-10-23. PMID:12185806. |
based on the review of the literature we believe that tic disorders are related to altered neurotransmitter function within the cns, especially that the functional abnormality is somehow related to dopaminergic mechanism. |
2002-10-23 |
2023-08-12 |
Not clear |
| Robyn Lints, Scott W Emmon. Regulation of sex-specific differentiation and mating behavior in C. elegans by a new member of the DM domain transcription factor family. Genes & development. vol 16. issue 18. 2002-10-17. PMID:12231628. |
in the male nervous system, mab-23 refines ray neuron subtype distribution by restricting expression of dopaminergic neurotransmitter identity through interactions with the hox gene egl-5 and a tgf-beta-related signaling pathway. |
2002-10-17 |
2023-08-12 |
caenorhabditis_elegans |
| Sanjeev Choudhary, Geetu Raheja, Vandana Gupta, Kiran Dip Gil. Possible involvement of dopaminergic neurotransmitter system in dichlorvos induced delayed neurotoxicity. Journal of biochemistry, molecular biology, and biophysics : JBMBB : the official journal of the Federation of Asian and Oceanian Biochemists and Molecular Biologists (FAOBMB). vol 6. issue 1. 2002-10-09. PMID:12186780. |
possible involvement of dopaminergic neurotransmitter system in dichlorvos induced delayed neurotoxicity. |
2002-10-09 |
2023-08-12 |
rat |
| Sanjeev Choudhary, Geetu Raheja, Vandana Gupta, Kiran Dip Gil. Possible involvement of dopaminergic neurotransmitter system in dichlorvos induced delayed neurotoxicity. Journal of biochemistry, molecular biology, and biophysics : JBMBB : the official journal of the Federation of Asian and Oceanian Biochemists and Molecular Biologists (FAOBMB). vol 6. issue 1. 2002-10-09. PMID:12186780. |
the present investigation was carried out to elucidate the possible involvement of the dopaminergic neurotransmitter system in the development of dichlorvos induced delayed neurotoxicity in the rat and to assess the protective efficacy of nimodipine against opidn (organophosphate induced delayed neurotoxicity). |
2002-10-09 |
2023-08-12 |
rat |
| Sanjeev Choudhary, Geetu Raheja, Vandana Gupta, Kiran Dip Gil. Possible involvement of dopaminergic neurotransmitter system in dichlorvos induced delayed neurotoxicity. Journal of biochemistry, molecular biology, and biophysics : JBMBB : the official journal of the Federation of Asian and Oceanian Biochemists and Molecular Biologists (FAOBMB). vol 6. issue 1. 2002-10-09. PMID:12186780. |
single subcutaneous dose of dichlorvos (200 mg/kg body weight) resulted in marked changes in the dopaminergic neurotransmitter system in terms of increased levels of both dopamine and norepinephrine along with significant increase in the activity of both the catecholamine synthesizing enzymes, tyrosine hydroxylase (th) and dopamine-beta-hydroxylase. |
2002-10-09 |
2023-08-12 |
rat |